secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001193125-24-160339
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney prices upsized $130M offering of 53.7M shares at $2.42 per share
--------------------------------------------------------------------------

- Total offering of 53,719,009 shares at $2.42/share; net proceeds expected ~$136.7M.
- Public offering of 42,744,220 shares; underwriters have 30-day option for 6,411,633 more.
- Concurrent direct offering of 11,030,574 shares to certain investors; closings not contingent.
- Expected close June 13; proceeds for clinical trials, R&D, pre-commercial activities.
- Jefferies, J.P. Morgan, Guggenheim lead underwriting; PJT Partners as co-manager/adviser.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000119312524160339/0001193125-24-160339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000119312524160339/d814183d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-160339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer